New Omicron Subvariant BQ.1.1 Resistant To All Therapeutic Antibodies
Published
Are the currently approved antibody therapies used to treat individuals at increased risk for severe COVID-19 disease also effective against currently circulating viral variants? A recent study by researchers at the German Primate Center (DPZ) – Leibniz Institute for Primate Research and Friedrich-Alexander University...
Full Article